BioLineRx Ltd.
BLRX
$2.55
-$0.04-1.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -89.01% | -15.60% | -41.76% | 75.20% | -176.85% |
| Total Depreciation and Amortization | -11.36% | 563.16% | -115.97% | -32.39% | 6.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 56.72% | 34.59% | -82.73% | -162.38% | 121.27% |
| Change in Net Operating Assets | -44.44% | 549.37% | 144.63% | -109.47% | 464.52% |
| Cash from Operations | -41.10% | 28.75% | -51.95% | -1,089.83% | 93.17% |
| Capital Expenditure | 200.00% | 76.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -200.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 134.11% | 968.27% | -108.47% | 199.17% | 54.57% |
| Cash from Investing | 134.85% | 902.08% | -109.18% | 199.16% | 54.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.34% | 5.75% | 0.32% | -0.08% | -0.64% |
| Issuance of Common Stock | -- | -- | -100.00% | -88.10% | -73.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.39% | 5.75% | -36.68% | -157.18% | -83.05% |
| Foreign Exchange rate Adjustments | 1,100.00% | -91.20% | 68.92% | -82.87% | 626.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 384.58% | 84.01% | -743.31% | 139.25% | -31.93% |